被撤回的出版物: Combination of Tanshinone IIA and Cisplatin Inhibits Esophageal Cancer by Downregulating NF-κB/COX-2/VEGF Pathway (Retracted article See vol 11, 2021)
机构:[1]Department of Traditional Chinese Medicine, The First Affiliated Hospital, Sun Yat-sen University, Guangzhou, China,中山大学附属第一医院[2]State Key Laboratory of Oncology in South China, Collaborative Innovation Center for Cancer Medicine, Sun Yat-sen University Cancer Center, Guangzhou, China,[3]Department of Oncology, The First Affiliated Hospital of Guangzhou University of Chinese Medicine, Guangzhou, China,[4]Peking Union Medical College Hospital, Peking Union Medical College, Chinese Academy of Medical Sciences, Beijing, China,[5]The Second Clinical College, Guangdong Provincial Academy of Chinese Medical Sciences, Guangzhou University of Chinese Medicine, Guangzhou, China,广东省中医院[6]The Seventh Affiliated Hospital, Sun Yat-sen University, Shenzhen, China,深圳医学信息中心中国医学科学院阜外医院深圳医院[7]School of Pharmaceutical Sciences, Sun Yat-sen University, Guangzhou, China
This work was supported by grants from the National
Key R&D Program of China (Nos. 2017YFC1309001
and 2016YFC1302305) and the National Natural
Science Foundation of China (Grant Nos. 81572359,
81602063, and 81730072).
第一作者机构:[1]Department of Traditional Chinese Medicine, The First Affiliated Hospital, Sun Yat-sen University, Guangzhou, China,[2]State Key Laboratory of Oncology in South China, Collaborative Innovation Center for Cancer Medicine, Sun Yat-sen University Cancer Center, Guangzhou, China,[3]Department of Oncology, The First Affiliated Hospital of Guangzhou University of Chinese Medicine, Guangzhou, China,
共同第一作者:
通讯作者:
推荐引用方式(GB/T 7714):
Xiaozhong Liao,Ying Gao,Jiahui Liu,et al.被撤回的出版物: Combination of Tanshinone IIA and Cisplatin Inhibits Esophageal Cancer by Downregulating NF-κB/COX-2/VEGF Pathway (Retracted article See vol 11, 2021)[J].FRONTIERS IN ONCOLOGY.2020,10:doi:10.3389/fonc.2020.01756.
APA:
Xiaozhong Liao,Ying Gao,Jiahui Liu,Lanting Tao,Jun Xie...&Suilin Mo.(2020).被撤回的出版物: Combination of Tanshinone IIA and Cisplatin Inhibits Esophageal Cancer by Downregulating NF-κB/COX-2/VEGF Pathway (Retracted article See vol 11, 2021).FRONTIERS IN ONCOLOGY,10,
MLA:
Xiaozhong Liao,et al."被撤回的出版物: Combination of Tanshinone IIA and Cisplatin Inhibits Esophageal Cancer by Downregulating NF-κB/COX-2/VEGF Pathway (Retracted article See vol 11, 2021)".FRONTIERS IN ONCOLOGY 10.(2020)